Lataa...
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
Poly(ADP-ribose) polymerase (PARP) inhibitors have recently been introduced in the therapy of several types of cancers not responding to conventional treatments. However, de novo and acquired PARP inhibitor resistance is a significant limiting factor in the clinical therapy, and the underlying mecha...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7139751/ https://ncbi.nlm.nih.gov/pubmed/32106627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12030532 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|